Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 303-311

  Nicklin, Martin J H ^a   Hughes, David E ^a   Barton, Jenny L ^a   Ure, Jan M ^b   Duff, Gordon W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aorta; Arteritis; Chronic disease; Interleukin 1; Vasculitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANEURYSM RUPTURE; ANIMAL TISSUE; ARTERITIS; ARTICLE; ATHEROSCLEROSIS; BLEEDING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

AGE OF ONSET; ALLELES; ANIMALS; ARTERITIS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0034677174     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.303     Document Type: Article

References (35)

1. Dinarello, C.A. 1996. Biologic basis for interleukin-1 in disease. Blood. 87:2095-2147.
2. Sims, J.E., C.J. March, D. Cosman, M.B. Widmer, H.R. MacDonald, C.J. McMahan, C.E. Grubin, J.M. Wignall, J.L. Jackson, S.M. Call, et al. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science. 241:585-589.
3. Kilian, P.L., K.L. Kaffka, A.S. Stern, D. Woehle, W.R. Benjamin, T.M. Dechiara, U. Gübler, J.J. Farrar, S.B. Mizel, and P.T. Lomedico. 1986. Interleukin 1-alpha and interleukin 1-beta bind to the same receptor. J. Immunol. 136:4509-4514.
4. Mizel, S.B., and D. Mizel. 1981. Purification to apparent homogeneity of murine interleukin-1. J. Immunol. 126:834-837.
5. French, J.F., L.E. Lambert, and R.C. Dage. 1991. Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther 259:260-264.
6. Saklatvala, J.L., M.C. Pilsworth, S.J. Sarsfield, J. Gavrilovic, and J.K. Heath. 1984. Pig catabolin is a form of interleukin-1. Biochem. J. 224:461-466.
7. Helle, M., J.P.J. Brakenhoff, E.R. de Groot, and L.A. Aarden. 1988. Interleukin-6 is involved in interleukin-1-induced activities. Eur. J. Immunol. 18:957-959.
8. Sica, A., K. Matsushima, J. van Damme, J.M. Wang, N. Polentarutti, E. Dejana, F. Colotta, and A. Mantovani. 1990. IL-1 transcriptionally activates the neutrophil chemotactic factor-IL-8 gene in endothelial cells. Immunology. 69:548-553.
9. Bochner, B.S., F.W. Luscinskas, M.A. Gimbrone, Jr., W. Newman, S.A. Sterbinsky, C.P. Derse-Anthony, D. Klunk, and R.P. Schleimer. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecule. J. Exp. Med. 173:1553-1557.
10. Eisenberg, S.P., R.J. Evans, W.P. Arend, E. Verderber, M.T. Brewer, C.H. Hannum, and R.C. Thompson. 1990. Primary structure and functional expression from complementary-DNA of a human interleukin-1 receptor antagonist. Nature. 343:341-346.
11. Arend, W.P., M. Malyak, M.F. Smith, Jr., T.D. Whisenand, J.L. Slack, J.E. Sims, J.G. Giri, and S.K. Dower. 1994. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J. Immunol. 153:4766-4774.
12. Greenfeder, S.A., P. Nunes, L. Kwee, M. Labow, P.A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:13757-13765.
13. Korherr, C., R. Hofmeister, H. Wesche, and W. Falk. 1997. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27:262-267.
14. Arend, W.P., M.F. Smith, Jr., R.W. Janson, and F.G. Joslin. 1991. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J. Immunol. 147: 1530-1536.
15. Fenton, M.J., J.A. Buras, and R.P. Donnelly. 1992. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149:1283-1288.
16. Dower, S.K., S.M. Call, S. Gillis, and D.L. Urdal. 1986. Similarity between the interleukin-1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc. Natl. Acad. Sci. USA. 83:1060-1064.
17. Chomarat, P., E. Vannier, J. Dechanet, M.C. Rissoan, J. Banchereau, C.A. Dinarello, and P. Miossec. 1995. Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. J. Immunol. 154:1432-1439.
18. Zahedi, K.A., C.M. Uhlar, M. Rits, A.E. Prada, and A.S. Whitehead. 1994. The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitro. Cytokine. 6:1-9.
19. Haskill, S., G. Martin, L. van Le, J. Morris, A. Peace, C.F. Bigler, G.J. Jaffe, C. Hammerberg, S.A. Sporn, S. Fong, et al. 1991. cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA. 88:3681-3685.
20. Gabay, C., B. Porter, G. Fantuzzi, and W.P. Arend. 1997. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J. Immunol. 159:5905-5913.
21. Muzio, M., N. Polentarutti, M. Sironi, G. Poli, L. De Gioia, M. Introna, A. Mantovani, and F. Colotta. 1995. Cloning and characterization of a new isoform of the interleukin-1 receptor antagonist. J. Exp. Med. 182:623-628.
22. Malyak, M., J.M. Guthridge, K.R. Hance, S.K. Dower, J.H. Freed, and W.P. Arend. 1998. Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J. Immunol. 161:1997-2003.
23. Gabay, C., M.F. Smith, D. Eidlen, and W.P. Arend. 1997. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Invest. 99:2930-2940.
24. Ross, R. 1993. The pathogenesis of atherosclerosis - a perspective for the 1990s. Nature. 362:801-809.
25. Raines, E.W., S.K. Dower, and R. Ross. 1989. Interleukin-1 mitogenic activity for fibroblasts and smooth-muscle cells is due to PDGF-AA. Science. 243:393-396.
26. Francis, S.E., N.J. Camp, R.M. Dewberry, J. Gunn. P. Syrris, N.D. Carter, S. Jeffery, J.C. Kaski, D.C. Cumberland, G.W. Duff, et al. 1999. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation. 99:861-866.
27. Hirsch, E., V.M. Irikura, S.M. Paul, and D. Hirsh. 1996. Functions of interleukin-1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA. 93:11008-11013.
28. Horai, R., M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura. 1998. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463-1475.
29. Mountford, P., B. Zevnik, A. Duwel, J. Nichols, M. Li, C. Dani, M. Robertson, I. Chambers, and A. Smith. 1994. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA, 91: 4303-4307.
30. Joyner, A.L., W.C. Skarnes, and J. Rossant. 1989. Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells, Nature. 338:153-156.
31. Beckwith, C.S., C.L. Franklin, R.R. Hook, Jr., C.L. Besch-Williford, and L.K. Riley. 1997. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J. Clin. Microbiol. 35:1020-1623.
32. Topper, J.N., J. Cai, D. Falb, and M.A. Gimbrone, Jr. 1996. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc. Natl. Acad. Sci. USA. 93:10417-10422.
33. Liao, F., J.A. Berliner, M. Mehrabian, M. Navab, L.L. Demer, A.J. Lusis, and M. Fogelman. 1991. Minimally modified low-density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87:2253-2257.
34. Dangler, C.A., S.E. Baker, M.K. Njenga, and S.H. Chia. 1995. Murine cytomegalovirus-associated arteritis. Vet. Pathol. 32:127-133.
35. Glaccum, M.B., K.L. Stocking, K. Charrier, J.L. Smith, C.R. Willis, C. Maliszewski, D.J. Livingston, J.J. Peschon, and P.J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor tor IL-1. J. Immunol. 159:3364-3371.